| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 50 |
| 1 | CARVEDILOL | 47 |
| 2 | TACROLIMUS | 44 |
| 3 | DARBEPOETIN ALFA | 42 |
| 4 | PANTOPRAZOLE | 41 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 41 |
| 6 | TACROLIMUS OINTMENT 0.1% | 41 |
| 7 | DOXAZOSIN MESYLATE | 40 |
| 8 | SODIUM BICARBONATE | 40 |
| 9 | SODIUM BICARBONATE INJECTION, | 40 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COCOA BUTTER, PHENYLEPHRINE HCL | 1 | 0.0196 |
| 1 | COCOA BUTTER, PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0054 |
| 2 | VADADUSTAT | 1 | 0.0033 |
| 3 | FLUVASTATIN SODIUM | 13 | 0.0029 |
| 4 | AMPHOTERICIN B | 29 | 0.0023 |
| 5 | TOLVAPTAN | 29 | 0.0019 |
| 6 | VALGANCICLOVIR | 37 | 0.0019 |
| 7 | CHOLESTERINUM | 2 | 0.0018 |
| 8 | SEVELAMER HYDROCHLORIDE | 1 | 0.0017 |
| 9 | TALIGLUCERASE ALFA | 1 | 0.0017 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipid-based Polyene Antifungal [EPC] | 29 | 0.0023 |
| 1 | Vasopressin V2 Receptor Antagonist [EPC] | 29 | 0.0019 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 32 | 0.0014 |
| 3 | Erythropoiesis-stimulating Agent [EPC] | 42 | 0.0008 |
| 4 | Polyene Antifungal [EPC] | 29 | 0.0007 |
| 5 | Antiseptic [EPC] | 2 | 0.0005 |
| 6 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 7 | alpha-Adrenergic Blocker [EPC] | 47 | 0.0003 |
| 8 | Arteriolar Vasodilator [EPC] | 24 | 0.0003 |
| 9 | 5-alpha Reductase Inhibitor [EPC] | 26 | 0.0003 |